Martin Haluzı́k

18.2k total citations · 3 hit papers
363 papers, 12.1k citations indexed

About

Martin Haluzı́k is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Martin Haluzı́k has authored 363 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Physiology, 117 papers in Endocrinology, Diabetes and Metabolism and 102 papers in Epidemiology. Recurrent topics in Martin Haluzı́k's work include Adipokines, Inflammation, and Metabolic Diseases (81 papers), Adipose Tissue and Metabolism (75 papers) and Regulation of Appetite and Obesity (74 papers). Martin Haluzı́k is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (81 papers), Adipose Tissue and Metabolism (75 papers) and Regulation of Appetite and Obesity (74 papers). Martin Haluzı́k collaborates with scholars based in Czechia, United States and United Kingdom. Martin Haluzı́k's co-authors include Miloš Mráz, D Haluzíková, Oksana Gavrilova, Marc L. Reitman, Z Lacinová, Kimihiko Matsusue, Frank J. Gonzalez, Ladislav Šenolt, Daniel Housa and I Dostálová and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Martin Haluzı́k

345 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass

2003 665 citations Oksana Gavrilova, Martin Haluzı́k et al. profile →
The role of adipose tissue immune cells in obesity and low-grade inflammation

2014 427 citations Miloš Mráz, Martin Haluzı́k profile →
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review

2022 132 citations Martin Haluzı́k et al. profile →

Peers

Countries citing papers authored by Martin Haluzı́k

Since Specialization

Citations

This map shows the geographic impact of Martin Haluzı́k's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Haluzı́k with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Haluzı́k more than expected).

Fields of papers citing papers by Martin Haluzı́k

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Haluzı́k. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Haluzı́k. The network helps show where Martin Haluzı́k may publish in the future.

Co-authorship network of co-authors of Martin Haluzı́k

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Haluzı́k. A scholar is included among the top collaborators of Martin Haluzı́k based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Haluzı́k. Martin Haluzı́k is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity 2024 ·Drugs ·(unknown), Miloš Mráz, Edward B. Jude, Martin Haluzı́k	11
2	The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol 2024 ·Diabetes Therapy ·Peter Novodvorský, (unknown), (unknown), Miloš Mráz, (unknown), (unknown), Péter Stella, (unknown), (unknown), Mireille Bonnemaire, Martin Haluzı́k	2
3	Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure 2024 ·Cardiovascular Diabetology ·(unknown), Miloš Mráz, Petr Svoboda, (unknown), Helena Kratochvílová, (unknown), (unknown), Peter Ivák, Petra Janovská, Tatyana Kobets, (unknown), (unknown), Lenka Mrázová, Viktor Stránecký, Ivan Netuka, Tomáš Čajka, Ondřej Kuda, Vojtěch Melenovský, Soňa Hubáčková, Martin Haluzı́k	11
4	Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation 2024 ·Diabetes Care ·(unknown), (unknown), (unknown), Miloš Mráz, Eva Kieslichová, (unknown), (unknown), (unknown), Peter Girman, Martin Haluzı́k, Janka Franeková, (unknown), David C. Klonoff, Michael A. Kohn, A Jabor	21
5	Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy 2021 ·Nutrients ·(unknown), Evžen Machytka, (unknown), (unknown), (unknown), Julius Špičák, (unknown), Martin Haluzı́k, Marek Bužga	13
6	In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia 2021 ·International Journal of Molecular Sciences ·Martina Hüttl, Irena Marková, (unknown), (unknown), Martin Poruba, Martin Haluzı́k, Ivana Vaněčková, Hana Malínská	28
7	Pheochromocytoma With Adrenergic Biochemical Phenotype Shows Decreased GLP-1 Secretion and Impaired Glucose Tolerance 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Ondřej Petrák, (unknown), Miloš Mráz, D Haluzíková, (unknown), Helena Kratochvílová, Z Lacinová, Květoslav Novák, David Michalský, Petr Waldauf, Robert Holaj, J Widimský, Tomáš Zelinka, Martin Haluzı́k	15
8	Spontaneous delivery is associated with increased endothelial activity in cord blood compared to elective cesarean section 2020 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), (unknown), (unknown), Martin Haluzı́k, (unknown), Jan Janota	6
9	<p>The relationship of mitochondrial dysfunction and the development of insulin resistance in Cushing’s syndrome</p> 2019 ·Diabetes Metabolic Syndrome and Obesity ·Jana Ježková, (unknown), László Wenchich, Hana Hansíková, J Zeman, Václav Hána, J Marek, Z Lacinová, Martin Haluzı́k, Michal Kršek	5
10	Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease 2019 ·Mediators of Inflammation ·Miloš Mráz, Anna Cinkajzlová, Jana Kloučková, Z Lacinová, Helena Kratochvílová, Michal Lipš, Michal Pořízka, Petr Kopecký, Jaroslav Lindner, Tomáš Kotulák, Ivan Netuka, Martin Haluzı́k	27
11	Influence of Duodenal–Jejunal Implantation on Glucose Dynamics: A Pilot Study Using Different Nonlinear Methods 2019 ·Complexity ·David Cuesta–Frau, Daniel Novák, (unknown), Daniel Abásolo, Tricia Adjei, Manuel Varela, (unknown), Miloš Mráz, Petra Kaválková, (unknown), Martin Haluzı́k	1
12	Endothelial Microvesicles and Soluble Markers of Endothelial Injury in Critically Ill Newborns 2018 ·Mediators of Inflammation ·(unknown), (unknown), (unknown), (unknown), (unknown), Martin Haluzı́k, J Živný, Jan Janota	21
13	[Long-acting insulins in the treatment of type 2 diabetes and their position in the current treatment algorithm]. 2017 ·PubMed ·Martin Haluzı́k	1
14	[The alarming incidence of gestational diabetes mellitus using currently used and new international diagnostic criteria]. 2014 ·PubMed ·Kateřina Anderlová, (unknown), Pavlína Klusáčková, (unknown), Hana Benaková, V. Krejčí, (unknown), Martin Haluzı́k	2
15	Cardiac Surgery Increases Serum Concentrations of Adipocyte Fatty Acid-Binding Protein and Its mRNA Expression in Circulating Monocytes but Not in Adipose Tissue 2014 ·Physiological Research ·Tomáš Kotulák, J. Drápalová, Michal Lipš, Z Lacinová, (unknown), (unknown), Ivan Netuka, J Malý, J Bláha, Jaroslav Lindner, Š Svačina, Miloš Mráz, Martin Haluzı́k	6
16	Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance. 2005 ·PubMed ·Martin Haluzı́k	35
17	Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice 2004 ·Journal of Clinical Investigation ·Shoshana Yakar, Jennifer Setser, Hong Zhao, Bethel Stannard, Martin Haluzı́k, Vaida Glatt, Mary Bouxsein, John J. Kopchick, Derek LeRoith	187
18	Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice 2004 ·Journal of Clinical Investigation ·Shoshana Yakar, Jennifer Setser, Hong Zhao, Bethel Stannard, Martin Haluzı́k, Vaida Glatt, Mary Bouxsein, John J. Kopchick, Derek LeRoith	164
19	Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes 2003 ·Journal of Clinical Investigation ·Kimihiko Matsusue, Martin Haluzı́k, Gilles Lambert, S Yim, Oksana Gavrilova, Jerrold M. Ward, Bryan Brewer, Marc L. Reitman, Frank J. Gonzalez	476
20	Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes 2003 ·Journal of Clinical Investigation ·Kimihiko Matsusue, Martin Haluzı́k, Gilles Lambert, S Yim, Oksana Gavrilova, Jerrold M. Ward, Bryan Brewer, Marc L. Reitman, Frank J. Gonzalez	478

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact